Verastem Oncology
VSTM
#7286
Rank
NZ$1.04 B
Marketcap
NZ$11.53
Share price
1.03%
Change (1 day)
-21.61%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2026 (TTM): -NZ$0.34 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are NZ$49.58 Million. In 2025 the company made an earning of -NZ$0.36 Billion a decrease over its 2024 earnings that were of -NZ$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.34 Billion-4.99%
2025 -NZ$0.36 Billion60.57%
2024 -NZ$0.22 Billion49.31%
2023 -NZ$0.15 Billion18.36%
2022 -NZ$0.13 Billion3.67%
2021 -NZ$0.12 Billion5.43%
2020 -NZ$0.12 Billion-54.74%
2019 -NZ$0.25 Billion105.99%
2018 -NZ$0.13 Billion6.83%
2017 -NZ$0.12 Billion86.06%
2016 -NZ$60.97 Million-37.03%
2015 -NZ$96.81 Million8.43%
2014 -NZ$89.28 Million29.52%
2013 -NZ$68.94 Million28.6%
2012 -NZ$53.61 Million133.9%
2011 -NZ$22.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.71 B-5,560.43%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.30 B-809.02%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$16.74 B-5,261.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-NZ$11.31 Million-96.52%๐Ÿ‡บ๐Ÿ‡ธ USA